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Objectives: High Bone Mass (HBM) is associated with (a) radiographic knee osteoarthritis (OA), partly mediated
by increased BMI, and (b) pelvic enthesophytes and hip osteophytes, suggestive of a bone-forming phenotype.
We aimed to establish whether HBM is associated with radiographic features of OA in non-weight-bearing
(hand) joints, and whether such OA demonstrates a bone-forming phenotype.
Methods: HBM cases (BMD Z-scores ≥ +3.2) were compared with family controls. A blinded assessor graded all
PA hand radiographs for: osteophytes (0–3), joint space narrowing (JSN) (0–3), subchondral sclerosis (0–1), at
the index Distal Interphalangeal Joint (DIPJ) and 1st Carpometacarpal Joint (CMCJ), using an established atlas.
Analyses used a random effects logistic regression model, adjusting a priori for age and gender. Mediating roles
of BMI and bone turnover markers (BTMs) were explored by further adjustment.
Results: 314HBMcases (mean age 61.1 years, 74% female) and 183 controls (54.3 years, 46% female)were included.
Osteophytes (grade ≥ 1)weremore common in HBM (DIPJ: 67% vs. 45%, CMCJ: 69% vs. 50%), with adjusted OR [95%
CI] 1.82 [1.11, 2.97], p=0.017 and 1.89 [1.19, 3.01], p=0.007 respectively; no differenceswere seen in JSN. Further
adjustment for BMI failed to attenuate ORs for osteophytes in HBM cases vs. controls; DIPJ 1.72 [1.05, 2.83], p =
0.032, CMCJ 1.76 [1.00, 3.06], p = 0.049. Adjustment for BTMs (concentrations lower amongst HBM cases) did
not attenuate ORs.
Conclusions:HBM is positively associatedwith OA in non-weight-bearing joints, independent of BMI. HBM-associat-
ed OA is characterised by osteophytes, consistent with a bone-forming phenotype, rather than JSN reﬂecting carti-
lage loss. Systemic factors (e.g. genetic architecture) which govern HBMmay also increase bone-forming OA risk.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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1. Introduction
Epidemiological studies have consistently demonstrated an associa-
tion between higher bone mineral density (BMD) and both prevalent
[1–4] and incident [5–7] radiographic osteoarthritis (OA) of large joints.
To gain insights into mechanisms underlying this BMD-OA relationship,
we recently studied the prevalence and phenotype of OA in a unique
High BoneMass (HBM) population.We have found that HBM individuals
have a higher prevalence of self-reported joint replacement and use of
non-steroidal anti-inﬂammatory drugs (NSAIDs) compared with family
controls [8]. An increased prevalence of radiographic hip OAwas also ob-
served inHBM individuals, particularlywith respect to bony features such
as osteophytosis and subchondral sclerosis, whereas little evidence was
seen for features reﬂecting cartilage loss such as joint space narrowing
(JSN) [9]. Further characterisation of knee OA revealed a similar, osteo-
phyte predominant, radiographicOAphenotype [10]. Additional evidence
of a ‘bone-forming’ tendency is supported by a greater prevalence and
severity of radiographic pelvic enthesophytes (bony spurs at tendon/liga-
ment insertions) seen in HBM individuals, comparedwith family controls
[11].
Interestingly, HBM individuals also tend to have a greater bodymass
index (BMI) [12], andwomenwith HBMhave elevated fatmass on total
body DXA with a particular tendency towards central adiposity [13].
Whilst genetic sequencing is ongoing, HBM cases are thought to have
a genetic predisposition to their raised BMD suggesting a causal path-
way whereby raised BMD leads to increased fat mass [13,14]. Mouse
models have suggested bone turnover directly inﬂuences insulin sensi-
tivity and adiposity via a relay involving osteocalcin (an osteoblast-
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speciﬁc protein) and adiponectin (an adipokine produced by white ad-
ipose tissue). Reduced bone turnover, resulting in decreased
osteocalcin, has been associatedwith lower adiponectin, impaired insu-
lin sensitivity, and increased fat deposition due to reduced energy ex-
penditure [6]. Obesity is an established risk factor for OA, particularly
in large weight-bearing joints; increased mechanical load is considered
deleterious to joints [12,15]. However, although greater BMI contribut-
ed in part to the association we observed between HBM and knee OA,
the association persisted after BMI adjustment [10], and the relationship
between HBM and hip OA appeared independent of BMI [9].
The observation that obesity is also associated with OA in non-
weight-bearing joints, i.e. the hand [16], suggests adiposity may also
modify OA risk viametabolic pathways, e.g. through increased circulat-
ing adipokines or chronic inﬂammation [17,18]. The relative importance
of these two pathways (mechanical vs. metabolic) in mediating the
BMI-OA association remains to be determined. We aimed to establish
whether HBM is associated with OA in non-weight-bearing joints, and
if so whether such OA also demonstrates a bone-forming phenotype
and whether increased BMI contributes to any identiﬁed association.
We hypothesized that, in line with our previous ﬁndings and evidence
from general population studies [11], HBM would be associated with a
‘bone-forming’ phenotype of OA in non-weight-bearing joints poten-
tially reﬂecting underlying systemic factors.
2. Methods
2.1. Participant recruitment
HBMcaseswere recruited as part of theUK-basedHBMstudy, amulti-
centre observational study of adultswith unexplainedHBM; full details of
DXA database screening and recruitment have previously been reported
[12]. Potential index cases were initially identiﬁed by screening 13 Na-
tional Health Service (NHS) DXA databases (335,115 DXA scans in total)
for T and/or Z-scores ≥ +4at any sitewithin the lumbar spine or hip. Pre-
vious case studies of HBM used Z-score thresholds to deﬁne HBM [19];
however, as Hologic DXA scanner databases store T- but not Z-scores,
our searchwas of T- and/or Z-score ≥+4. All DXA imageswere inspected
by trained clinicians to exclude scans with artefactual elevation of DXA
BMD, resulting in 49.4% of scans being excluded due to degenerative dis-
ease/osteoarthritis/scoliosis, and a further 15.5% for other reasons includ-
ing surgical/malignant/Pagetic artefacts etc. To reduce contamination of
our remaining DXA scans by more moderate OA, we aimed to reﬁne our
case deﬁnition based upon restriction to speciﬁc lumbar verterba(e). At
our largest centre 463 antero-posterior DXA scans with T/Z-score ≥+4
were graded for OA severity by lateral Kellgren & Lawrence scores, and
examined in relation to BMD at lumbar vertebral levels [20,21]. Total
L1-L4 Z-score was strongly associated with increasing KL score (β coefﬁ-
cient 1.01 [0.54, 1.48], p b 0.001) [21]; in contrast to other lumbar verte-
brae, L1 Z-scorewas not associatedwith the presence of OA (0.04 [−0.53,
0.60], p = 0.89) [21], reﬂecting the recognized pattern of progressive OA
changes seen in descending sequential lumbar vertebrae [22,23]. Nor did
total hip Z-score reﬂect lumbar spine OA [21]. As a generalised HBM trait
is expected to affect both spine and hip BMD, though not necessary to the
sameextent,we reﬁned ourHBM index case deﬁnition as having either a)
L1 Z-score ≥ +3.2 plus total hip Z-score ≥ +1.2 or b) total hip Z-
score ≥+3.2 plus L1 Z-score ≥+1.2. A + 3.2 threshold was consistent
with the only published precedent for identifying HBM using DXA [24]
and most appropriately differentiated generalised HBM from artefact. Z
rather than T-score limited age bias.
Further HBM cases were identiﬁed through DXA assessment of the
relatives and spouses of index cases. In ﬁrst-degree relatives, HBM
was deﬁned as a summed L1 Z-score plus total hip Z-score ≥ +3.2
(12). BMD was standardized using established formulae [25,26]. 41%
of relatives screened were affected and combined with HBM index
cases, with remaining unaffected ﬁrst-degree relatives/spouses forming
a family control group. Standardized clinical assessments, performed by
a doctor or research nurse, including a structured interview, clinical ex-
amination and weight and height measurement, were identical in both
HBM cases and controls. Concurrently, PA dominant hand X-rays were
performed in all participants according to local protocols at each centre.
Those reporting joint pain/aching/stiffness [27] for months/years in the
X-rayed hand were deﬁned as having a clinical history consistent with
OA. Recruitment ran July 2005–April 2010. Written informed consent
was obtained from all participants in linewith theDeclaration of Helsin-
ki [28]. Participants were excluded if aged b18, pregnant or unable to
provide written informed consent for any reason. This study was ap-
proved by the BathMulti-centre Research Ethics Committee (REC refer-
ence 05/Q2001/78) and at each NHS Local REC.
2.2. Assessment of radiographs
All available HBM case and control radiographs, collected across all
study centres, were pooled for assessment. Files were relabelled and pre-
sented in a random order to ensure blinding of the assessor. Radiographs
were gradedby a single observer (AM) following training by an individual
with previous experience of radiographic OA scoring (SH). X-ray images
(all PA) were stored as DICOM ﬁles and viewed using open source ImageJ
software [29]; semi-quantitative assessments were recorded.
We assessed two joints in the hand; the index Distal Interphalangeal
Joint (DIPJ) and 1st Carpometacarpal Joint (CMCJ), chosen as they are
themost commonly affected byOA (inwomen, andour population is pre-
dominantly female) [30]. Each joint was assigned a semi-quantitative
grading of individual radiographic features of OA (osteophytes, joint
space narrowing and subchondral sclerosis) using the established Altman
atlas [31], and the presence or absence ofmal-alignment (at theDIPJ), and
cysts (at the CMCJ) (Table 1). Categorical scores for the individual radio-
graphic features were converted to binary variables for analysis.
Image quality was rated by the operator at the time of assessment
(good, poor, very poor); very poor X-rays, judged in terms of penetration
or resolution,were excluded (n=3). At the end of the study 40 randomly
selected hand X-rays were re-graded by the primary observer (AM) and
by a secondary observer (SH), to assess intra-rater and inter-rater repeat-
ability respectively. Unweighted intra-rater kappa values for the above
listed binary variables were all ≥ 0.60 (considered substantial agreement
[32]), except CMCJ JSN where binarized as ‘moderate’ (JSN grade ≥ 2)
(0.53 [95% CI 0.07, 1.00]), but when binarized as ‘any JSN’ (JSN
grade ≥ 1) agreement was better (0.74 [95% CI 0.53, 0.95]); DIPJ mal-
alignment and CMCJ cysts were not seen amongst this subgroup. The
inter-rater kappas for all measurements were N0.60, except CMCJ
subchondral sclerosis which was rarely seen (0.23 [95% CI−0.21, 0.67]).
2.3. Assessment of covariates
Values for age (at time of X-ray), gender and BMI were obtained. BMI
was calculated as weight (kg)/height (metres2). Two non-fasted EDTA
samples were collected and plasma separated and frozen within 4 h to
Table 1
Semi-quantitative scoring of radiographic features of CMCJ and DIPJ osteoarthritis. Grad-
ing of individual radiographic features was performed using the Altman atlas [31]. OP =
osteophyte.
OA feature Categorical
grading
Binary variable(s)
Osteophytes 0–3 Any osteophyte (any OP grade ≥ 1),
moderate osteophyte (any OP grade ≥ 2)
Joint space narrowing
(JSN)
0–3 Any JSN (JSN grade ≥ 1), moderate JSN
(JSN grade ≥ 2)
Subchondral
sclerosis
0–1 Subchondral sclerosis (grade ≥ 1)
Mal-alignment
(DIPJ only)
0–1 Mal-alignment (grade ≥ 1)
Cysts (CMCJ only) 0–1 Cysts (grade ≥ 1)
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−80 °C. Bone formation (Procollagen type 1 amino-terminal propeptide
[P1NP], total osteocalcin) and resorption (β-C-telopeptides of type I colla-
gen [βCTX]) markers were measured. All had inter- and intra-assay
coefﬁcients of variation b 6.0% across the assay working ranges.
Electrochemiluminescence immunoassays (ECLIA) (Roche Diagnostics,
Burgess Hill, UK) were used to measure plasma concentrations of P1NP,
osteocalcin, and βCTX (detection limits 4.0, 0.6, 0.01 μg/L respectively).
Current and life-time physical activity (PA) was measured by postal
questionnaire comprising (i) the short last 7 days International PA
Questionnaire (IPAQ2002, http://www.ipaq.ki.se/ipaq.htm [33,34])
and (ii) historical PA questionnaire [35–37]. 87.3% completed PA ques-
tionnaires: thosewhodid not respondhad similar anthropometric char-
acteristics to those who did (Supplementary Table 1).
2.4. Statistical analysis
Demographic statistics for the HBM cases and family controls were
summarised as mean (SD) for continuous variables and counts (per-
centages) for categorical variables. Categorical variables were initially
cross-tabulated and percentages calculated: the chi-squared (χ2) test
was used to assess the association between binary variables, and the un-
paired t-test to compare mean values (or normally distributed vari-
ables) between cases and controls. Associations between HBM case
status and binary radiographic OA outcomes were analysed using logis-
tic regression in a random effects model, to allow for the lack of statisti-
cal independence due to within-family clustering of environmental
factors and shared genotypes. Analyses were adjusted for the a priori
confounders; age and gender, then additionally for (i) BMI and (ii)
bone turnover, as potential mediators. The potential inﬂuence of other
potential confounderswas assessed. Odds ratios before and after adjust-
ment are presented with 95% conﬁdence intervals (95% CI). Analyses
were repeated stratiﬁed by gender.
Pre-planned sensitivity analyses comprised: i) exclusion of poorer
quality X-rays, ii) excluding HBM cases/controls with self-reported in-
ﬂammatory arthritis, iii) excludingHBMcases/controlswith self-reported
steroid use (current or historical), and iv) restricting analyses to HBM
cases meeting the index case deﬁnition at the hip. Data were analysed
using Stata release 12 statistical software (StataCorp, College Station, TX,
USA).
3. Results
3.1. Participant selection and characteristics
Fig. 1 summarises the selection of radiographs for inclusion in our
analysis. Of the original study population 500 had X-rays performed;
those who did not (n = 55) were similar in all characteristics other
than theyweremore likely to bemale, and henceweremarginally taller
and reported higher levels of current physical activity (Supplementary
Table 2). Excluding 3 very poor quality X-rays permitted analyses in
314 HBM cases and 183 controls; demographics are detailed in Table
2. HBM cases were generally older and were more likely to be female,
post-menopausal and have used estrogen replacement, and had greater
BMI compared with controls. As expected, cases had substantially
higher BMD and BMD Z-scores than controls (Supplementary Fig. 1).
92.8% of the study population were right hand dominant.
3.2. HBM and clinical hand OA
HBM casesmore frequently reported a clinical history, and had exam-
ination ﬁndings, consistent with overall hand OA (Table 3); however,
these ﬁndings were fully attenuated by age and gender adjustment
(Table 4).
3.3. HBM and radiographic features of hand OA: unadjusted analyses
Osteophytes were more commonly seen amongst HBM cases than
controls, at both the DIPJ and CMCJ, whether graded as any osteophyte
(≥grade 1) (DIPJ: 67% vs. 45%; CMCJ 69% vs. 50%; in HBM vs. controls re-
spectively), or restricted to moderate and/or more severe osteophytes
(≥grade 2) (DIPJ: 29% vs. 14%; CMCJ 30% vs. 15%; in HBM vs. controls re-
spectively), p b 0.001 for all (Table 3). No differences between groups
Fig. 1. Flow diagram summarising selection of radiographs for inclusion in the study. Selection of High BoneMass (HBM) case and family control X-rays (process of recruitment to study
described previously). 1Reason recorded for missing X-rays in HBM cases: unable to travel (n = 7), no X-rays at study centre (n = 10), unable to attend/wait/comply (n = 3), patient
declined (n = 6), reside abroad (n = 2), reason unknown (n = 11). 2Reason recorded for missing X-ray in family controls: unable to travel (n = 1), did not continue in study (n =
1), no X-rays at study centre (n = 4), unable to attend/wait/comply (n = 3), patient declined (n = 2), reason unknown (n = 5).
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were seen in the frequency of either any (≥grade 1) ormoderate (≥grade
2) JSN at the DIPJ. At the CMCJ, JSN (≥grade 1) was observed equally fre-
quently amongst HBM cases and controls; however, more marked JSN
(≥grade 2), whilst being uncommon overall, was seen more often
amongst HBM cases than family controls (11.8% vs. 3.8% respectively;
p b 0.003). Subchondral sclerosis was uncommon overall, but observed
more frequently amongst HBM cases than controls, at both joint sites
(DIPJ: 8% vs. 3%; CMCJ 12% vs. 7%; in HBM vs. controls respectively). Al-
though DIPJ mal-alignment and CMCJ cysts occurred more commonly
amongst HBM cases, these features were rarely observed.
3.4. HBM and radiographic features of hand OA: analyses adjusted for age
and gender
After adjustment for age and gender clear associations persisted
between HBM case status and osteophytes, with HBM cases having
increased odds of ≥grade 1 osteophytes at the DIPJ (OR 1.82 [95%
CI 1.11, 2.97], p = 0.017) and CMCJ (1.89 [1.19, 3.01], p = 0.007),
and of ≥grade 2 osteophytes at the CMCJ (1.85 [1.07, 3.22], p =
0.028) (Table 4; Fig. 2). In contrast no association was seen between
HBM case status and JSN, at either joint site. Furthermore, the asso-
ciations between HBM case status and subchondral sclerosis, DIPJ
mal-alignment and CMCJ cysts, were fully attenuated by age and
gender adjustment.
3.5. HBM and radiographic features of hand OA: analyses with further
adjustments
Todetermine the extent towhich BMImight lie on the causal pathway
between HBM and osteophytic OA, we further adjusted our age and gen-
dermodel for BMI (Table 4; Fig. 2). Further BMI adjustmentmarginally at-
tenuated point estimates for osteophyte associations, but otherwise
similar patterns were still observed. Further adjustment for other poten-
tial confounders (menopausal status, diabetes mellitus, estrogen replace-
ment, steroid use) widened conﬁdence intervals but did not inﬂuence
overall results (Supplementary Table 3). As physical activitywas not asso-
ciatedwith HBM status this was not considered as a potential confounder
(Table 1).
To investigate the role differences in bone turnover might play in
explaining the association between HBM and osteophytic OA, we
analysed data from 475 individuals (96% of study population) in
whom bone turnover marker measures were available, and compared
our model adjusted for age, gender, BMI, with results further adjusted
for CTX, P1NP and osteocalcin (Supplementary Table 4). Adjustment
for bone turnover markers did not alter associations or point estimates.
Table 2
Demographics of study population.
HBM: High Bone Mass. SD: standard deviation. BMI: body mass index. PA: physical activ-
ity. IPAQ: International Physical Activity Questionnaire.
HBM cases (n = 314) Controls (n = 183) p value
Mean (SD) Mean (SD)
Age (years) 61.1 (14.1) 54.3 (16.3) b0.001
Height (cm) 167.1 (8.7) 171.1 (10.2) b0.001
Weight (kg) 85.6 (16.9) 83.2 (17.4) 0.109
BMI (kg/m2) 30.8 (5.8) 28.5 (5.0) b0.001
L1 Z-score 3.96 (1.5) 0.56 (1.2) b0.001
Total hip Z-score 3.04 (1.2) 0.63 (0.89) b0.001
P1NP (μg/L)a 36.1 (19.9) 40.7 (22.3) 0.022
Osteocalcin (total) (μg/L)a 15.8 (7.9) 18.0 (8.0) 0.003
CTX (μg/L)a 0.20 (0.13) 0.24 (0.17) 0.005
HBM cases (n = 314) Controls (n = 183) p value
n (%) n (%)
Female 234 (74.5) 84 (45.9) b0.001
Postmenopausal 187 (80.6) 45 (55.6) b0.001
Estrogen replacement
use (ever)b
109 (51.4) 15 (20.8) b0.001
Diabetes mellitus 37 (11.8) 12 (6.6) 0.064
Self-reported osteoarthritis 72 (22.9) 28 (15.3) 0.040
Self-reported
inﬂammatory arthritis
20 (6.4) 2 (1.1) 0.013
Steroid use (ever)c 82 (26.5) 31 (17.7) 0.030
Previous fractured 120 (38.2) 85 (46.7) 0.065
Current PA (IPAQ) (n = 434)
Low 45 (14.3) 19 (10.4)
Moderate 104 (33.1) 53 (29.0) 0.188
High 132 (42.0) 81 (44.3)
Historical PA scoree (n = 431)
Very low (0–4) 33 (10.5) 17 (9.3) 0.288
Low (5–7) 56 (17.8) 40 (21.9)
Moderate (8–10) 60 (19.1) 36 (19.7)
High (11–14) 66 (21.0) 28 (15.3)
Very high (15–24) 63 (20.1) 32 (17.5)
a n = 475.
b Post-menopausal estrogen replacement therapy.
c Previous or current, includes eye drops, intra-articular steroid injections and oral
steroids for e.g. asthma, PMR, ulcerative colitis.
d From any mechanism.
e Constructed using best available evidence, grading PA between 0 (no PA) & 24 (very
high PA) [35–37].
Table 3
Unadjusted osteoarthritis variables at the index Distal Interphalangeal Joint (DIPJ) and 1st Carpometacarpal Joint (CMCJ).
JSN: joint space narrowing; OR: odds ratio
HBM cases
(n 314)
Controls
(n 183)
OR (95% CI) p value
n (%) n (%)
Symptomatic hand OAa
Clinical history of hand OA 91 (29.0) 31 (16.9) 2.08 (1.29, 3.36) 0.003
Clinical exam suggesting hand OA 89 (28.3) 33 (18.0) 1.89 (1.17, 3.05) 0.009
DIPJ radiographic grading
Any osteophyte (≥grade 1) 210 (66.9) 83 (45.4) 2.51 (1.69, 3.73) b0.001
Moderate osteophytes (≥grade 2) 92 (29.3) 26 (14.2) 2.61 (1.58, 4.33) b0.001
Any JSN (≥grade 1) 122 (38.9) 61 (33.3) 1.29 (0.87, 1.91) 0.213
Moderate JSN (≥grade 2) 22 (7.0) 11 (6.0) 1.20 (0.55, 2.58) 0.649
Subchondral sclerosis 25 (8.0) 6 (3.3) 2.58 (1.02, 6.55) 0.046
Mal-alignment 17 (5.4) 1 (0.5) 11.0 (1.42, 84.9) 0.022
CMCJ radiographic grading
Any osteophyte (≥grade 1) 218 (69.4) 92 (50.3) 2.33 (1.56, 3.49) b0.001
Moderate osteophytes (≥grade 2) 94 (29.9) 27 (14.8) 2.55 (1.56, 4.18) b0.001
Any JSN (≥grade 1) 134 (42.7) 73 (39.9) 1.13 (0.77, 1.67) 0.521
Moderate JSN (≥grade 2) 37 (11.8) 7 (3.8) 3.65 (1.53, 8.71) 0.003
Subchondral sclerosis 38 (12.2) 12 (6.6) 2.05 (1.01, 4.13) 0.045
Cysts 11 (3.5) 1 (0.5) 7.25 (0.90, 58.6) 0.063
a Clinical history and examination ﬁndings relate to the same side as was X-rayed for each individual.
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3.6. Gender stratiﬁed analyses
Associations betweenHBMand radiographic features of OA at theDIPJ
were similar across men and women (Supplementary Table 5). Associa-
tions between HBM and CMCJ osteophytes (both ≥grade 1 and ≥grade
2) appeared stronger in women than men; however, no formal evidence
of a gender interaction was detected (p = 0.65 and 0.19 respectively).
3.7. Sensitivity analyses
25 X-rays (19 HBM cases; 6 controls) were considered to be of poor
quality in terms of resolution/penetration. Excluding these from the
analyses did not materially inﬂuence the observed associations (Sup-
plementary Table 6). 22 participants reported a history of inﬂammatory
arthritis (20 HBM cases; 2 controls). Exclusion from analyses again did
not inﬂuence the observed associations (Supplementary Table 7). Ex-
clusion of 113 individuals who reported previous and/or current use
of steroids, and 12 individuals in whom we lacked data regarding ste-
roid use, widened the conﬁdence interval but did not materially inﬂu-
ence the point estimate for the association between HBM status and
CMCJ osteophytes ≥ grade 2, otherwise ﬁndings were unchanged (Sup-
plementary Table 8). Amongst HBM cases, 166 individuals had a total
hip Z-score b +3.2. When comparing the remaining 148 HBM cases
and 183 controls point estimates were broadly consistent with the
main analysis, although conﬁdence intervals widened. There remained
a clear association between HBM status and CMCJ osteophytes ≥ grade
1 (2.03 [1.12, 3.69], p = 0.020) (Supplementary Table 9).
4. Discussion
We have shown an increased prevalence of radiographic features of
OA in non-weight-bearing joints of the hand, amongst HBM individuals
compared with family controls, similar to that we previously identiﬁed
in the weight-bearing joints of the knee and hip [9,10]. As we had hy-
pothesized, osteophyte measures were more strongly and consistently
associated with HBM, than was JSN, consistent with a ‘bone-forming’
phenotype of OA, again in line with our ﬁndings at the larger joints [9,
10]. However, unlike the association we identiﬁed between HBM and
knee OA, which attenuated by approximately 50% after BMI adjustment
[10], BMI adjustment did not inﬂuence HBM-osteophyte associations
for any radiological grade at either the DIPJ or CMCJ. These ﬁndings sug-
gest that HBM-osteophyte associations in the hand are independent of
weight-bearing and of BMI/metabolic factors. Interestingly, despite
lower bone turnovermeasured amongst HBM cases, further adjustment
for bone turnover markers, to investigate their potential role on the
causal pathway, failed to account for the HBM-osteophyte association.
Subchondral sclerosis, a further ‘bone-forming’ feature of OA, whilst
uncommon overall, was more prevalent amongst HBM cases than
Table 4
Osteoarthritis variables at the index Distal Interphalangeal Joint (DIPJ) and 1st Carpometacarpal Joint (CMCJ) adjusted for age and sex, with additional adjustment for BMI.
JSN: joint space narrowing; OR: odds ratio. Based on 314 HBM cases and 183 controls.
OR (95% CI) p value OR (95% CI) p value
Adjusted for age & sex Adjusted for age & sex & BMI
Symptomatic hand OAa
Clinical history of hand OA 1.20 (0.72, 1.99) 0.493 1.15 (0.68, 1.94) 0.595
Clinical exam suggesting hand OA 1.03 (0.61, 1.73) 0.908 1.05 (0.62, 1.78) 0.849
DIPJ radiographic grading
Any osteophyte (≥grade 1) 1.82 (1.11, 2.97) 0.017 1.72 (1.05, 2.83) 0.032
Moderate osteophytes (≥grade 2) 1.51 (0.86, 2.65) 0.155 1.47 (0.83, 2.61) 0.183
Any JSN (≥grade 1) 0.85 (0.54, 1.34) 0.492 0.76 (0.48, 1.21) 0.242
Moderate JSN (≥grade 2) 0.65 (0.29, 1.46) 0.297 0.65 (0.28, 1.47) 0.301
Subchondral sclerosis 1.22 (0.46, 3.23) 0.687 1.40 (0.52, 3.72) 0.505
Mal-alignment 5.33 (0.67, 42.7) 0.115 4.77 (0.59, 38.5) 0.142
CMCJ radiographic grading
Any osteophyte (≥grade 1) 1.89 (1.19, 3.01) 0.007 1.76 (1.10, 2.83) 0.019
Moderate osteophytes (≥grade 2) 1.85 (1.07, 3.22) 0.028 1.75 (1.00, 3.06) 0.049
Any JSN (≥grade 1) 0.85 (0.55, 1.31) 0.449 0.77 (0.50, 1.21) 0.256
Moderate JSN (≥grade 2) 1.87 (0.75, 4.66) 0.181 1.68 (0.67, 4.22) 0.272
Subchondral sclerosis 0.97 (0.46, 2.05) 0.928 1.02 (0.48, 2.18) 0.957
Cysts 3.73 (0.44, 31.5) 0.226 3.71 (0.43, 32.0) 0.233
a Clinical history and examination ﬁndings relate to the same side as was X-rayed for each individual.
Fig. 2. Odds ratios for osteophytes (≥grade 1) at the index Distal Interphalangeal Joint (DIPJ) (A) and 1st Carpometacarpal Joint (CMCJ) (B); stratiﬁed by gender and combined. Square
symbols represent point estimates aged for age and gender when combined. Circular symbols represent point estimates aged for age and BMI, as well as gender when combined. No
evidence for a gender interaction was identiﬁed. (Males n = 179, Females n = 318, Combined n = 497.) OR and 95% CI shown.
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family controls in unadjusted analyses. DIPJ mal-alignment and CMCJ
cystswere also observedmore frequently amongst HBMcases than con-
trols; however, generally thesewere rare and fully accounted for by be-
tween-group differences in age and gender. After taking account of age,
gender and BMI, overall odds ratios for osteophytes (≥grade 1) in HBM
cases vs. controls were similar at the DIPJ (1.72 [1.05, 2.83]), and CMCJ
(1.76 [1.10, 2.83]) as previously reported at the hip (2.12 [1.61, 2.79])
[9] and the knee (1.62 [1.21, 2.15]) [10], suggesting that the increased
risk of osteophytes conferred as a direct result of HBM (independent
of BMI) is similar across all joint sites.
Our ﬁndings are consistent with epidemiological evidence from the
general population, that increased BMD is a risk factor for hand OA [1,
38,39]. Whilst a number of studies have assessed the relationship be-
tween BMD and radiographic OA of knees and hips, many fewer have
focussed on the hand. Of those that have, most use the global score of
Kellgren and Lawrence [20], rather than feature-speciﬁc grades as we
have done [40]. Although, one study from 1995 examined radiographic
hand OA in 300 healthy older women, deriving global osteophyte and
JSN scores (graded 0–30) using 10 joints. Interestingly the osteophyte,
but not JSN score was positively correlated with BMD, apparently inde-
pendent of BMI although data were not shown [38]; authors speculated
bone density and osteophytosis may therefore have common genetic
determinants. More recently, a larger Korean study identiﬁed a positive
relationship between BMD and both hand osteophytes and sclerosis,
with an inverse relationship seen between BMD and JSN in the hand
[41], highlighting the importance of individual grading of OA sub-
phenotypes.
ExtremeHBM is likely to be genetically determinedwith onset of el-
evated bone mass developing relatively early in life, likely before the
onset of OA; the genetic basis of increased BMD in our HBM population
is currently being investigated [42]. Potentially, the genetic inﬂuences
governing BMD might also affect cartilage and OA risk. Wnt signalling
is an important regulator of osteoblastic bone formation and mutations
activating this pathwayproduce aHBMphenotype [19]. Polymorphisms
in genes thought to regulate the Wnt pathway, plus reduced levels of
the Wnt pathway inhibitor DKK1, have both been associated with
knee OA [43–45]. Furthermore, osteophytes formby endochondral ossi-
ﬁcation, reactivation of which is thought to play an important role in OA
development in adult joints [46–48]. Polymorphisms associated with
OA susceptibility lie close to genes involved in the regulation of endo-
chondral ossiﬁcation [49]. Interestingly, genetic variation at loci associ-
ated with both endochondral ossiﬁcation and Wnt signalling [50], is
greater amongst our HBM population [14]. Therefore, despite lack of
temporal data, we consider the relationships we report here, to most
likely reﬂect either a causal pathway between higher BMD and in-
creased risk of ‘bone-forming’ features of OA, or genetic pleiotropy.
It remains theoretically possible that OA features within the DXA ﬁeld
(e.g. lumbar osteophytosis) could lead to artefactual elevation of mea-
sured BMD, with the potential to induce a spurious HBM-OA association
if spine and hand OA are correlated as part of a “generalised OA” pheno-
type. As discussed, every effort was made within the study design to
avoid such misclassiﬁcation of HBM status; DXA scans were visually
inspected for artefactual causes of raised BMD including signiﬁcant OA,
and the L1 vertebra was selected for case deﬁnition as L1 Z-scores were
not associated with features of OA visible on lumbar DXA [12,21]. In
fact, this approach may have led to some individuals with both HBM
and OA being excluded, which if anythingwould bias our results towards
thenull. Reassuringly, hipOAhas been shown toonlyminimally inﬂuence
measured hip BMD [51], and sensitivity analyses limited to HBM cases
with hip predominant HBM generated point estimates similar to overall
results.
4.1. Limitations
Since controls were recruited fromwithin families, they are likely to
have greater similarity to HBM cases than unrelated general population
controls; hence clustered analyses were performed to account for
the lack of statistical independence due to within-family clustering
of environmental factors and shared genotypes. Despite this, our re-
ported differences may still underestimate the true magnitude of the
HBM phenotype. Considering referral indications for clinical DXA
services, our study design most likely accounts for the observed dif-
ferences between cases and controls in gender, age, post-menopaus-
al status, estrogen replacement and steroid use. However, older age,
greater body weight and female gender are all established risk fac-
tors for OA [16,52], and symptomatic hand OA is particularly seen
in post-menopausal women [53]. As the HBM cases were older,
more likely to be female and post-menopausal, and have a higher
BMI than family controls, our results may be explained by residual
confounding as regression models may not fully adjust for these
marked differences.
Some radiographs for both cases and controls were unavailable; less
mobile participants with OAmay have been less likely to have attended
for X-rays, potentially leading to underestimation of the true OA preva-
lencewithin our study population.We lacked data regarding any histor-
ic hand joint injuries as well as precise joint speciﬁc examination
ﬁndings, hence our reporting of global hand OA, which meant the po-
tential differences between ﬁnger and thumb examination ﬁndings
could not be determined. Between-centre variations in radiographic
protocols may have introduced measurement error; however, in affect-
ing both cases and controls, the expected effect would be to bias our re-
sults towards the null. We lack temporal data, so the direction of
causality cannot be formally assessed; nevertheless, we assume the
onset of genetically determined HBM would predate the onset of OA
(a disease of later life) in this population. However, it is theoretically
possible that OA features within the DXA ﬁeld (e.g. lumbar
osteophytosis) could lead to artefactual elevation of measured BMD,
with the potential to induce a spurious association between HBM and
OA if spine and hand OA are correlated as part of a “generalised OA”
phenotype. As discussed, every effort wasmade to avoid suchmisclassi-
ﬁcation of HBM status through both inspection of DXA images and our
case deﬁnition; also the fact that the association between HBM and
hand OA remained robust when restricted to those HBM cases with
high hip BMD is reassuring (Supplementary Table 9), as hip OA is
thought to have only a minimal inﬂuence on measured hip BMD [51].
A single blinded observer graded all radiographs, which may have led
to either over or underestimation of OAprevalence rather than affecting
between-group differences; this strategy was chosen as intra-rater re-
peatability of semi-quantitative OA scoring is substantially superior to
that between observers [54]. Ideally all radiographs would have been
dual graded, enabling robust calculation of agreement for rarer
characteristics.
5. Conclusion
In conclusion, our ﬁndings support a positive association between
HBM and osteophytosis in non-weight-bearing joints of the hand,
which is independent of BMI. HBM-associated OA is characterised by
osteophytes, consistent with a ‘bone forming’ phenotype, rather than
JSN reﬂecting cartilage loss, and is similar to the phenotype we have
previously reported in weight-bearing joints of the knee and hip [9,
10]. However, this ‘bone forming’ hand phenotype is not explained by
the lower bone turnover seen in adult HBM cases. It is possible that
the same systemic factors, for example genetic architecture, which gov-
ern HBM may also increase the risk of osteophytosis.
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